Literature DB >> 6282073

Effect of purine nucleotides and other compounds on the uptake of histamine and histidine.

E S Assem.   

Abstract

The uptake of 14C-ring labelled histamine and histidine was studied in human and guinea-pig leucocytes, and in rat peritoneal mast cells. Histamine uptake by sensitized human leucocytes was partly released by antigen or anti-IgE challenge, suggesting that histamine is taken up by the same cells that synthesize and secrete that amine, i.e. basophils. Histamine antagonists, particularly of the H2-subclass, had an inhibitory effect, but histamine agonists had a relatively small and inconsistent effect. Adrenoceptor stimulants and phosphodiesterase inhibitors produced small effects, but dibutyryl cAMP at a concentration of 4-10 mM consistently increased histamine uptake by more than 100% during a 30 min incubation. By contrast, ATP exerted an inhibitory effect, starting at a concentration of 0.2 mM and reaching a maximum (90% inhibition) at 10 mM. Histidine uptake was inhibited by ATP and slightly stimulated by cAMP. Propranolol caused stimulation of histamine uptake and inhibition of histidine uptake at micromolar concentrations. These results suggest that the uptake of histamine is not due to simple diffusion. Although it does not contribute significantly to total cell histamine content or to the removal mechanism of extracellular histamine, it may contribute to the auto-regulatory processes modulating histamine release, synthesis and metabolism. It may also have a significant effect on the extracellular level of histamine, under the influence of drugs or in pathological states.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6282073     DOI: 10.1007/bf01965146

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  10 in total

1.  Proceedings: Inhibition by antigen and by histamine antagonists of the uptake of histamine by isolated human leucocytes.

Authors:  E S Assem
Journal:  Br J Pharmacol       Date:  1976-03       Impact factor: 8.739

2.  Inhibition and stimulation of histamine release by oxatomide.

Authors:  C W Bierman; E S Assem; J L Mongar
Journal:  Int J Immunopharmacol       Date:  1979

3.  Purification of basophilic leukocytes from guinea pig blood and bone marrow.

Authors:  H F Dvorak; S S Selvaggio; A M Dvorak; R B Colvin; D B Lean; J Rypysc
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

4.  Inhibition of histamine release by histamine controlled by H2 receptor.

Authors:  L M Lichtenstein; E Gillespie
Journal:  Nature       Date:  1973-08-03       Impact factor: 49.962

5.  Antagonism by beta-adrenoceptor blocking agents of the antianaphylactic effect of isoprenaline.

Authors:  E S Assem; H O Schild
Journal:  Br J Pharmacol       Date:  1971-08       Impact factor: 8.739

6.  Metabolic studies of guinea pig basophilic leukocytes in short-term tissue culture. I. Measurement of histaminesynthesizing capacity by using an isotopic-thin layer chromatographic assay.

Authors:  S J Galli; A S Galli; A M Dvorak; H F Dvorak
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

7.  The ATP4- receptor of rat mast cells.

Authors:  S Cockcroft; B D Gomperts
Journal:  Biochem J       Date:  1980-06-15       Impact factor: 3.857

8.  Histamine release induced by human leukocyte lysates. Reabsorption of previously released histamine after exposure to cyclic amp-active agents.

Authors:  M T Kelly; A White
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

9.  Histamine increases histidine uptake by basophils.

Authors:  J Stewart; A B Kay
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

10.  Metabolic studies on the uptake of [14C]-histidine and [14C]-histamine and histamine synthesis by guinea-pig basophils, in vitro.

Authors:  J Stewart; D G Jones; A B Kay
Journal:  Immunology       Date:  1979-03       Impact factor: 7.397

  10 in total
  1 in total

1.  Evidence of a dual role of endogenous histamine in angiogenesis.

Authors:  K Norrby
Journal:  Int J Exp Pathol       Date:  1995-04       Impact factor: 1.925

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.